Cookies help us delivering our services on https://together.kickcancer.org. If you keep browsing this website, you are accepting our use of cookies for statisitic purpose and social network functionalities.

Close

François van Marsenille

by françois van Marsenille

300 €

raised so far. Fundraising target 200 €

150%

project
over

6

donations

I donate to this page

Individual page

Share this fundraising page

Project
Donations
Comments

I decided to register for RUN TO KICK because I wanted to support the cause of research against children's cancer carried by KickCancer.

Today, there is too little innovation in favour of children with cancer: most greatest leaps forward in the field of cancer, which the medias rave about, only benefit to the adult population... despite the facts that paediatric cancers are the first cause of death by disease and that 2/3 children's cancer survivors have to go through life with severe side effects caused by their treatments.

It is urgent to cure more children and to cure them better.

I participate in RUN TO KICK so that I can shoot children's cancer and send it far, far away and may it never come back!

By supporting my race, you will help me shooting farther and harder. Thank you! 

See all

23/09/2018

Hugo Van de Cauter

50 €

21/09/2018

Edouard Van Marsenille

50 €

Bravo pour cette belle initiative. Bon Run!

21/09/2018

30 €

allez Paco

17/09/2018

Frédéric van Marsenille

20 €

12/09/2018

50 €

Félicitations pour cette belle initiative! Que ces dons soient profitables à ceux qui en ont besoin.

12/09/2018

TTR Energy (TTR Energy)

100 €

See all

Add a new comment

See all

About KickCancer

We have a mission. A beautiful mission. We want to cure every child’s cancer.
Find new treatments, improve existing ones, and kick children’s cancer to send it far, far away forever and may it never come back!
We therefore financially support scientific research, and bring together the drive, inspiration and knowledge of everyone involved.  From researchers, doctors and parents to politicians and pharmaceutical companies.